Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Updated on: May 26,2026

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Updated on:May 26,2026

Supportive cancer care: Most patients say human touch outshines tech

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew researchpublishedin the November 2025 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkexplores the percep

Updated on: April 02,2026

Supportive cancer care: Most patients say human touch outshines tech

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew researchpublishedin the November 2025 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkexplores the percep

Updated on:April 02,2026

New analytical method reveals how drug combinations act in leukemia

byTampere UniversityCoPISA workflow and possible states for target discovery in combinatorial therapy. Credit:Nature Communications(2026). DOI: 10.1038/s41467-026-70394-3Acute myeloid leukemia (AML) r

Updated on: May 15,2026

New analytical method reveals how drug combinations act in leukemia

byTampere UniversityCoPISA workflow and possible states for target discovery in combinatorial therapy. Credit:Nature Communications(2026). DOI: 10.1038/s41467-026-70394-3Acute myeloid leukemia (AML) r

Updated on:May 15,2026

Subtyping colorectal cancer may improve patient outcome predictions

byKyoto UniversityAn example usage of General Colorectal Cancer Signature (GCS). Credit: KyotoU / Makoto TaketoColorectal cancer, or CRC, is the world's second most lethal cancer based on the numb

Updated on: April 01,2026

Subtyping colorectal cancer may improve patient outcome predictions

byKyoto UniversityAn example usage of General Colorectal Cancer Signature (GCS). Credit: KyotoU / Makoto TaketoColorectal cancer, or CRC, is the world's second most lethal cancer based on the numb

Updated on:April 01,2026

Discovery of pancreatic tumor vulnerability could pave the way for new treatments

by Evelyne Dufresne,McGill UniversityCredit:Molecular Cancer(2026). DOI: 10.1186/s12943-026-02587-9A team from the Research Institute of the McGill University Health Center (The Institute), led by Jea

Updated on: June 05,2026

Discovery of pancreatic tumor vulnerability could pave the way for new treatments

by Evelyne Dufresne,McGill UniversityCredit:Molecular Cancer(2026). DOI: 10.1186/s12943-026-02587-9A team from the Research Institute of the McGill University Health Center (The Institute), led by Jea

Updated on:June 05,2026

Promising drug can inhibit aggressive breast cancer

by Erik Robinson,Oregon Health & Science UniversityGraphical abstract. Credit:Cell Reports Medicine(2025). DOI: 10.1016/j.xcrm.2025.102451New research reveals a drug developed by scientists at Ore

Updated on: March 23,2026

Promising drug can inhibit aggressive breast cancer

by Erik Robinson,Oregon Health & Science UniversityGraphical abstract. Credit:Cell Reports Medicine(2025). DOI: 10.1016/j.xcrm.2025.102451New research reveals a drug developed by scientists at Ore

Updated on:March 23,2026

RNA-based molecule enhances therapies against pancreatic cancer

byItalian Institute of TechnologyThe small ring-like structures visible in the magnified area represent the RAD51 protein, which has adopted a non-functional shape as a result of its interaction with

Updated on: March 27,2026

RNA-based molecule enhances therapies against pancreatic cancer

byItalian Institute of TechnologyThe small ring-like structures visible in the magnified area represent the RAD51 protein, which has adopted a non-functional shape as a result of its interaction with

Updated on:March 27,2026

Prostate cancer cells use unique metabolic pathway to thrive in bone tissue

by Elizabeth Chapin,University of KentuckyFong with members of his lab. Credit: University of KentuckyA University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their

Updated on: March 24,2026

Prostate cancer cells use unique metabolic pathway to thrive in bone tissue

by Elizabeth Chapin,University of KentuckyFong with members of his lab. Credit: University of KentuckyA University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their

Updated on:March 24,2026

Scientists show targeting cancer stem cells can prevent gastric cancer recurrence

byAgency for Science, Technology and Research (A*STAR), SingaporeAQP5 is a functional marker of mouse and human gastric cancer stem cells. Credit:Science(2025). DOI: 10.1126/science.adr2428Scientists

Updated on: March 31,2026

Scientists show targeting cancer stem cells can prevent gastric cancer recurrence

byAgency for Science, Technology and Research (A*STAR), SingaporeAQP5 is a functional marker of mouse and human gastric cancer stem cells. Credit:Science(2025). DOI: 10.1126/science.adr2428Scientists

Updated on:March 31,2026

Radiotherapy after mastectomy can be avoided, study finds

byUniversity of EdinburghCredit: Ivan Samkov from PexelsRadiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a

Updated on: March 27,2026

Radiotherapy after mastectomy can be avoided, study finds

byUniversity of EdinburghCredit: Ivan Samkov from PexelsRadiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a

Updated on:March 27,2026

Targeting B-cells may boost immunotherapy in liver cancer treatment

byHouston MethodistICB immunotherapy increased B-cell infiltration. Credit:Nature Communications(2025). DOI: 10.1038/s41467-025-66581-3Scientists have identified a promising strategy to improve liver

Updated on: April 03,2026

Targeting B-cells may boost immunotherapy in liver cancer treatment

byHouston MethodistICB immunotherapy increased B-cell infiltration. Credit:Nature Communications(2025). DOI: 10.1038/s41467-025-66581-3Scientists have identified a promising strategy to improve liver

Updated on:April 03,2026

New understanding of T cell receptors may improve cancer immunotherapies

byRockefeller UniversityThe gray portion of this schematic represents a nanodisk, where for the first time researchers were able to replicate the native membrane environment (red dots) of a T-cell rec

Updated on: March 21,2026

New understanding of T cell receptors may improve cancer immunotherapies

byRockefeller UniversityThe gray portion of this schematic represents a nanodisk, where for the first time researchers were able to replicate the native membrane environment (red dots) of a T-cell rec

Updated on:March 21,2026